<DOC>
	<DOCNO>NCT01105403</DOCNO>
	<brief_summary>The purpose study determine whether POL6326 safe clinically active mobilize hematopoietic stem cell follow transplantation</brief_summary>
	<brief_title>Exploratory Study POL6326 Stem Cell Mobilization</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>1 . Have multiple myeloma Stage II III , accord criterion Durie Salmon . 2 . Male female 18 70 year age , inclusive . Male female capable reproduction must agree use adequate contraceptive measure ( e.g . condom , intrauterine device , oral contraceptive ) 3 month termination treatment . 3 . Measurable disease , define one following : Serum M protein ≥1.0 g/dL protein electrophoresis Quantifiable immunoglobulin level and/or urinary M protein excretion ≥200 mg/24 hour . 4 . All patient undergo 3 cycle chemotherapy , last dose chemotherapy give 3 8 week study entry . 5 . Eastern Cooperative Oncology Group ( ECOG ) performance status 2 . 6 . Life expectancy &gt; 6 month . 7 . Have give write informed consent participate study 1 . Have nonsecretory myeloma and/or plasma cell leukaemia . 2 . History malignancy past 5 year , exception adequately treat basal squamous cell carcinoma skin , cervical carcinoma , localised prostate carcinoma . 3 . Any clinically significant medical condition . 4 . History cardiac disease NHYA classification ≥3 . 5 . Insufficient bone marrow , liver renal function assess follow clinical laboratory evaluation : Haemoglobin &lt; 9.0 g/L . Absolute neutrophil count &lt; 1500/µL . Platelet count &lt; 50000/µL . Total bilirubin &gt; 1.5 x upper limit normal ( ULN ) . Alanine aminotransferase ( ALT ) alkaline phosphatase ( AP ) &gt; 2.5 x ULN . Amylase lipase &gt; 1.5 x ULN . Serum creatinine &gt; 2.0 x ULN . Prothrombin time ( PT ) activate partial thromboplastin time ( aPTT ) &gt; 1.5 x ULN . 6 . Pregnant lactate female patient . 7 . Known history HIV infection chronic hepatitis B C infection . 8 . Receipt immunotherapy , radiation therapy , investigational drug within 30 day study drug administration . 9 . Prior radiotherapy 3 vertebra . 10 . Active serious bacterial fungal infection ; &gt; grade 3 National Cancer Institute ( NCI ) Common Terminology Criteria Adverse Events ( CTCAE ) . 11 . Receipt haematopoietic cytokine within 10 day study drug administration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Hematopoietic stem cell</keyword>
	<keyword>Mobilisation</keyword>
	<keyword>Autologous transplantation</keyword>
</DOC>